Lineage Cell Therapeutics In shares owned by Allegheny Financial Group
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Allegheny Financial Group
from 13F filings
Historical chart of Allegheny Financial Group investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Allegheny Financial Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Allegheny Financial Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $22k | 20k | 1.09 |
| 2023-09-30 | $24k | 20k | 1.18 |
| 2023-03-31 | $30k | 20k | 1.50 |
| 2022-12-31 | $23k | 20k | 1.17 |
| 2022-09-30 | $22k | 20k | 1.10 |
| 2022-06-30 | $32k | 20k | 1.60 |
| 2022-03-31 | $31k | 20k | 1.55 |
| 2021-12-31 | $49k | 20k | 2.45 |
| 2021-09-30 | $50k | 20k | 2.50 |
| 2021-06-30 | $57k | 20k | 2.85 |
| 2021-03-31 | $47k | 20k | 2.35 |
| 2020-12-31 | $35k | 20k | 1.75 |